BioSpace News Archive

Drug Development

Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Shows That Health-Related Quality-Of-Life Is Higher In ABSSSI Patients Deemed Cured Vs Improved After End Of Treatment

April 10, 2015
·
4 min read
Trinity Biotech Closes Offering Of $115 Million Of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise In Full Of Option To Purchase Additional Notes

April 10, 2015
·
6 min read
Business

Genticel Strengthens Management Team And Appoints Valerie Leroy As Senior Director, Corporate Communications And Investor Relations

April 10, 2015
·
4 min read
Deals

Forward Pharma Pre-IPO Investors Voluntarily Agree To Extend Lock-Up

April 10, 2015
·
2 min read
uniQure Announces Pricing Of Follow-On Public Offering

April 10, 2015
·
2 min read
Drug Development

Cesca Therapeutics Management Provides Update On Clinical Trials For Critical Limb Ischemia (“CLI”) And Acute Myocardial Infarction (“AMI”)

April 10, 2015
·
6 min read
BioCapital

New Research Shows PharmaCyte Biotech’s Melligen Cell Line Can Reverse Diabetes

April 10, 2015
·
5 min read
Biotech Bay

Intuitive Surgical Reports New Employee Option Grants For April 2015

April 10, 2015
·
3 min read
Drug Development

ChromaDex, Inc. Release: Published Study Shows Topical Treatment With Pterostilbene Effectively Protects Hairless Mice Against UVB Radiation-Induced Skin Damage And Carcinogenesis

April 10, 2015
·
5 min read
Biotech Bay

Cellular Biomedicine Group Upgraded To NASDAQ Global Market

April 10, 2015
·
2 min read